Sign in
4

Changes in Ownership

LIFECORE BIOMEDICAL, INC. DE Filed Acc 0001437749-16-035613

Options or other derivatives

  • Chief Executive Officer acquired 200,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hemmeter Molly · Chief Executive Officer

Table II: Derivative

2 lines
Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
2016-07-21 Exercise or conversion : show line 1 in the form Incentive Stock Option (Right to Buy) +150,000 $11.35 $1,702,500 $11.35 2023-07-21 150,000 150,000 D
2016-07-21 Exercise or conversion : show line 2 in the form Right to Buy Restricted Stock Unit (RSU) +50,000 50,000 50,000 D
Loading xslF345X03/rdgdoc.xml…